Molecular approaches to the drug enhancement of deteriorated functioning in the aged.
D000433:1-Propanol / Q000378:metabolism; D000375:Aging / Q000187:drug effects*; D000605:Amino Alcohols / Q000378:metabolism; D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D001921:Brain / Q000201:enzymology; D003071:Cognition / Q000187:drug effects; D004247:DNA / Q000096:biosynthesis; D003851:Deoxyribonucleases / Q000378:metabolism; D005246:Feedback; D005609:Free Radicals; D006801:Humans; D006931:Hyperbaric Oxygenation; D002534:Hypoxia, Brain / Q000378:metabolism; D007288:Inosine / Q000378:metabolism; D007858:Learning / Q000187:drug effects; D046911:Macromolecular Substances; D008568:Memory / Q000187:drug effects; D008722:Methods; D051379:Mice; D008954:Models, Biological; D008967:Molecular Biology; D010389:Pemoline / Q000494:pharmacology; D010672:Phenytoin / Q000494:pharmacology; D011342:Procainamide / Q000494:pharmacology; D014176:Protein Biosynthesis; D011600:Psychopharmacology; D012313:RNA / Q000096:biosynthesis; D012260:Ribonucleases / Q000378:metabolism; D012270:Ribosomes / Q000378:metabolism; D014273:Triflupromazine / Q000494:pharmacology; D014508:Urea / Q000494:pharmacology
D000605:Amino Alcohols; D005609:Free Radicals; D046911:Macromolecular Substances; D007288:Inosine; D010672:Phenytoin; D012313:RNA; D010389:Pemoline; D014508:Urea; D004247:DNA; D000433:1-Propanol; D000661:Amphetamine; D003851:Deoxyribonucleases; D012260:Ribonucleases; D011342:Procainamide; D014273:Triflupromazine